Ingredion Incorporated meldet Ergebnisse für das vierte Quartal und das Gesamtjahr 2020 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Share:
BUENA, N.J., Dec. 31, 2020 (GLOBE NEWSWIRE) Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter ended September 30, 2020.
Financial Highlights
Third Quarter 2020 vs. Second Quarter 2020
Revenues of $14.3 million, an increase of $0.8 million or 6%, on stronger demand for US topical products
Gross profit of $0.1 million, a decrease of $2.4 million driven by additional inventory reserves and write offs
Product development and research expenses of $2.4 million, an increase of $0.5 million due to API write offs for development programs not being pursued
Selling, general and administrative expenses of $6.5 million, an increase of $1.6 million or 31% driven by increased professional fee for debt and strategic consulting and bad debt expense